Tarceva Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II
Conditions:   Solid Tumor;   Advanced Solid Tumor;   Metastatic Cancer Interventions:   Drug: Alectinib;   Drug: Atezolizumab;   Drug: Erlotinib;   Drug: Trastuzumab + Pertuzumab;   Drug: Trastuzumab emtansine;   Drug: Vemurafenib;   Drug: Bevacizumab + Erlotinib;   Drug: Entrectinib Sponsors:   Seoul National University Bundang Hospital;   Korean Cancer Study Group;   Roche Pharma AG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 2, 2022 Category: Research Source Type: clinical trials